Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia

• Maciej Grzywnowicz ,

  Contributed equally to this work with: Maciej Grzywnowicz, Joanna Zaleska

  Affiliation Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  ⨯
• Joanna Zaleska ,

  Contributed equally to this work with: Maciej Grzywnowicz, Joanna Zaleska

  Affiliation Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  ⨯
• Daniel Mertens,

  Affiliations Department of Internal Medicine III, University of Ulm, Ulm, Germany, Cooperation Unit “Mechanisms of Leukemogenesis", German Cancer Research Center, Heidelberg, Germany

  ⨯
• Waldemar Tomczak,

  Affiliation Department of Hematooncology and Bone Marrow Transplantation Unit, Medical University of Lublin, Lublin, Poland

  ⨯
• Paulina Wlasiuk,

  Affiliation Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  ⨯
• Kamila Kosior,

  Affiliation Department of Hematooncology and Bone Marrow Transplantation Unit, Medical University of Lublin, Lublin, Poland

  ⨯
• Agnieszka Piechnik,

  Affiliation Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

  ⨯
• Agnieszka Bojarska-Junak,

  Affiliation Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland

  ⨯
• Anna Dmoszynska,

  Affiliation Department of Hematooncology and Bone Marrow Transplantation Unit, Medical University of Lublin, Lublin, Poland

  ⨯
• Krzysztof Giannopoulos

  * E-mail: giannop@tlen.pl

  Affiliations Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland, Department of Internal Medicine III, University of Ulm, Ulm, Germany, Department of Hematooncology and Bone Marrow Transplantation Unit, Medical University of Lublin, Lublin, Poland

  ⨯